ES8504462A1 - Procedimiento de obtencion de una composicion farmaceutica a base de inmunoglobulina y fibronectina. - Google Patents

Procedimiento de obtencion de una composicion farmaceutica a base de inmunoglobulina y fibronectina.

Info

Publication number
ES8504462A1
ES8504462A1 ES523795A ES523795A ES8504462A1 ES 8504462 A1 ES8504462 A1 ES 8504462A1 ES 523795 A ES523795 A ES 523795A ES 523795 A ES523795 A ES 523795A ES 8504462 A1 ES8504462 A1 ES 8504462A1
Authority
ES
Spain
Prior art keywords
fibronectin
immune globulin
pharmaceutical composition
produce
amounts sufficient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES523795A
Other languages
English (en)
Other versions
ES523795A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of ES523795A0 publication Critical patent/ES523795A0/es
Publication of ES8504462A1 publication Critical patent/ES8504462A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE UNA COMPOSICION FARMACEUTICA A BASE DE INMUNOGLOBULINA Y FIBRONECTINA.CONSISTE EN PONER EN CONTACTO EN UNA SOLUCION ACUOSA ESTERIL, A TEMPERATURA AMBIENTE Y A UN PH FISIOLOGICAMENTE ACEPTABLE, INMUNOGLOBULINA Y FIBRONECTINA PURIFICADAS. LA INMUNOGLOBULINA ES INMUNOGLOBULINA INTRAVENOSA O INMUNOGLOBULINA DE SUERO Y SE UTILIZA EN CANTIDADES DE 0,01 A 1.000 PARTES POR PARTES DE FIBRONECTINA, SOBRE UNA BASE DE PESO/PESO.SE UTILIZAN PARA LA PROFILAXIS Y EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS Y NO INFECCIOSAS CON DEFECTOS DE OPSONIZACION IN VIVO Y ANORMALIDADES DEL SISTEMA RETICULOENDOTELIAL.
ES523795A 1982-07-02 1983-07-01 Procedimiento de obtencion de una composicion farmaceutica a base de inmunoglobulina y fibronectina. Expired ES8504462A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/394,977 US4412990A (en) 1982-07-02 1982-07-02 Composition having enhanced opsonic activity

Publications (2)

Publication Number Publication Date
ES523795A0 ES523795A0 (es) 1985-04-16
ES8504462A1 true ES8504462A1 (es) 1985-04-16

Family

ID=23561169

Family Applications (1)

Application Number Title Priority Date Filing Date
ES523795A Expired ES8504462A1 (es) 1982-07-02 1983-07-01 Procedimiento de obtencion de una composicion farmaceutica a base de inmunoglobulina y fibronectina.

Country Status (7)

Country Link
US (1) US4412990A (es)
EP (1) EP0098431B1 (es)
JP (1) JPS5920229A (es)
AT (1) ATE23270T1 (es)
CA (1) CA1208555A (es)
DE (1) DE3367328D1 (es)
ES (1) ES8504462A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001505A1 (en) * 1982-10-21 1984-04-26 Minneapolis Med Res Opsonins in peritoneal dialysis
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
US4894328A (en) * 1986-03-26 1990-01-16 Board Of Regents, The University Of Texas System Immunodiagnostic test for syphilis and other treponemal infections
CA1310267C (en) * 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
JP2547556B2 (ja) * 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US7238668B1 (en) * 1989-09-01 2007-07-03 Fred Hutchinson Cancer Research Center Inhibition of lymphocyte adherence with CS-1-peptides and fragments thereof
US20080139789A1 (en) * 1990-10-22 2008-06-12 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
WO1994015640A1 (en) * 1993-01-12 1994-07-21 Anthony George Gristina Methods and compositions for the direct concentrated delivery of passive immunity
EP0921816A4 (en) * 1996-03-28 2004-09-22 Whitehead Biomedical Inst CELLS WITH INCREASED OPSONINE CONTENT AND METHOD FOR REGULATING AN IMMUNE RESPONSE TO ANTIQUE
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
EP2625263B1 (en) 2010-10-08 2020-03-11 Terumo BCT, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
CN104053670A (zh) 2011-10-31 2014-09-17 百时美施贵宝公司 具有降低的免疫原性的纤连蛋白结合域
WO2015073918A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3122866B1 (en) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. CELL EXPANSION
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
EP3656842A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2848529A1 (de) * 1978-11-09 1980-05-29 Behringwerke Ag Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions

Also Published As

Publication number Publication date
EP0098431A3 (en) 1984-09-12
DE3367328D1 (en) 1986-12-11
JPH0585525B2 (es) 1993-12-07
ES523795A0 (es) 1985-04-16
EP0098431B1 (en) 1986-11-05
JPS5920229A (ja) 1984-02-01
EP0098431A2 (en) 1984-01-18
CA1208555A (en) 1986-07-29
ATE23270T1 (de) 1986-11-15
US4412990A (en) 1983-11-01

Similar Documents

Publication Publication Date Title
DE3367328D1 (en) Pharmaceutical composition comprising immune globulin and fibronectin
GB2071670B (en) Nutrient compositions and methods of administering the same
DE3569188D1 (en) A method of making a food composition containing inositoltriphosphate and the composition
EP0129778A3 (en) Cell-stimulating composition
PT76314A (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
EP0123239A3 (en) Improvements in or relating to antiprotozoal agents
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
IL75805A (en) Pharmaceutical immunosuppressor compositions containing lycorine
DE3165600D1 (en) Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
ZA849076B (en) Device for prophylaxis and treatment of various diseases
NZ224116A (en) Compositions of interleukin-2 and fk565; method of stimulation of the immune system and package
HUT64691A (en) Cosmetic preparative with skin regenerative effect
ZA855822B (en) Pharmaceutical compositions for the treatment of involutional brain syndromes and mental decay
ES2009249A6 (es) Composicion cosmetica regeneradora de la piel a base de algas que contengan selenio.
JPS5721354A (en) Esters of carnitine alkoxy-acyl derivatives, manufacture and medicinal composition as effective component thereof
JPS55113721A (en) Immunity regulator
ZA833997B (en) Basic esters exhibiting an antagonistic activity to calcium,process for the preparation thereof and pharmaceutical compositions therefrom
DE3572187D1 (en) Additive-containing paints
ZA79197B (en) Pharmaceutical compositions and their use in the profylaxis and/or treatment of certain diseases
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
DE3474897D1 (en) Timed release delivery means for delivery of active agent to spatially separated terrain locations and compositions comprised thereby
SE8300495D0 (sv) Improvements in or relating to nasal pharmaceutical compositions
OA09771A (en) Asphodelus composition for increasing white blood cell count.
ES8702162A1 (es) Procedimiento para preparar composiciones autoemulsionables a base de fluoroclorohidrocarburos y de esteres fosforicos
PT76389B (en) Process for the preparation of 7-alpha-aminoacyl-3-chlorocepha-losporins having and anti-infections effect and their use for the preparation of pharmaceutical compositions having an anti-infections effect